Authors:
Domingo-Domenech, E
de Sanjose, S
Gonzalez-Barca, E
Romagosa, V
Domingo-Claros, A
Gil-Vernet, S
Figueras, J
Manito, N
Oton, B
Petit, J
Granena, A
de Sevilla, AF
Citation: E. Domingo-domenech et al., Post-transplant lymphomas: a 20-year epidemiologic, clinical and pathologic study in a single center, HAEMATOLOG, 86(7), 2001, pp. 715-721
Authors:
Hueso, M
Bover, J
Espinosa, L
Moreso, F
Seron, D
Canas, C
Raulf, F
Bianco, A
Gil-Vernet, S
Carreras, M
Castelao, AM
Grinyo, JM
Alsina, J
Citation: M. Hueso et al., TGF-beta(1) gene expression in protocol biopsies from patients with stablerenal allograft function, TRANSPLAN P, 33(1-2), 2001, pp. 342-344
Authors:
Seron, D
Moreso, F
Lopez, M
Vallejos, A
Giordani, C
Gil-Vernet, S
Castelao, AM
Grinyo, JM
Citation: D. Seron et al., Arterial intimal thickening in stable renal allografts during the first year of follow-up, TRANSPLAN P, 33(1-2), 2001, pp. 1293-1294
Authors:
Casanovas-Taltavull, T
Baliellas, C
Benasco, C
Serrano, T
Casanova, A
Perez, JL
Guerrero, L
Gonzalez, T
Andres, E
Gil-Vernet, S
Casais, LA
Citation: T. Casanovas-taltavull et al., Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: Results after transplantation, AM J GASTRO, 96(4), 2001, pp. 1170-1177
Authors:
Cruzado, JM
Torras, J
Gil-Vernet, S
Grinyo, JM
Citation: Jm. Cruzado et al., Glomerulonephritis associated with hepatitis C virus infection after renaltransplantation, NEPH DIAL T, 15, 2000, pp. 65-67
Authors:
Seron, D
Moreso, F
Ramon, JM
Hueso, M
Condom, E
Fulladosa, X
Bover, J
Gil-Vernet, S
Castelao, AM
Alsina, J
Grinyo, JM
Citation: D. Seron et al., Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy, TRANSPLANT, 69(9), 2000, pp. 1849-1855
Authors:
Jaurrieta, E
Casais, L
Figueras, J
Ramos, E
Lama, C
Rafecas, A
Taltavull, TC
Fabregat, J
Xiol, X
Torras, J
Baliellas, C
Sabate, A
Rufi, G
Benasco, C
Casanovas, T
Serrano, T
Gil-Vernet, S
Sabate, I
Busquets, J
Citation: E. Jaurrieta et al., Analysis of 500 liver transplantations in the Bellvitge Hospital, Spain, MED CLIN, 115(14), 2000, pp. 521-529
Authors:
Moreso, F
Seron, D
Gil-Vernet, S
Riera, L
Fulladosa, X
Ramos, R
Alsina, J
Grinyo, JM
Citation: F. Moreso et al., Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients, NEPH DIAL T, 14(4), 1999, pp. 930-935
Authors:
Hueso, M
Bover, J
Seron, D
Gil-Vernet, S
Rufi, G
Alsina, J
Grinyo, JM
Citation: M. Hueso et al., The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate - cure with ketoconazole and allopurinol, NEPH DIAL T, 14(12), 1999, pp. 2941-2943
Authors:
Martinez-Castelao, A
Grinyo, JM
Fiol, C
Castineiras, MJ
Hurtado, I
Gil-Vernet, S
Seron, D
Porta, I
Minarro, A
Villarroya, A
Alsina, J
Citation: A. Martinez-castelao et al., Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients, KIDNEY INT, 56, 1999, pp. S231-S234
Authors:
Torras, J
Figueras, J
Lama, C
Fabregat, J
Ramos, E
Rafecas, A
Gil-Vernet, S
Pares, D
Busquets, J
Jaurrieta, E
Citation: J. Torras et al., Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity, TRANSPLAN P, 31(6), 1999, pp. 2430-2430
Authors:
Hueso, M
Bover, J
Seron, D
Gil-Vernet, S
Sabate, I
Fulladosa, X
Ramos, R
Coll, O
Alsina, J
Grinyo, JM
Citation: M. Hueso et al., Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function, TRANSPLANT, 66(12), 1998, pp. 1727-1731